Original articleThe phenotype spectrum of X-linked ichthyosis identified by chromosomal microarray
Section snippets
Methods
Diagnostic screening of postnatal peripheral blood specimens from 23,172 consecutive cases (13,945 male patients) submitted to the Mayo Clinic Cytogenetics Laboratory from March 4, 2008 to September 3, 2013 for CMA analysis using either a 4x44K or 4x180K oligonucleotide–based whole-genome cytogenomic microarray (Agilent Technologies, Santa Clara, CA) or Cytoscan HD array (Affymetrix, Santa Clara, CA) identified 22 cases of deletions that overlapped the STS gene (cases 1-22). Further information
Results
In all, 22 cases with an STS deletion were identified by CMA studies (Fig 1, A). For the 5 patients with accessible medical records, skin description, extracutaneous phenotypes, and gene content of the associated X chromosome deletion are described (Table I). Based on the American College of Medical Genetics guidelines for CMA testing,25 it is not surprising that the referral indications provided for almost all patients included developmental delay, autism, and/or dysmorphic features. Five of
Discussion
The potential impact to families of an XLI diagnosis is exemplified by literature describing at least 5 pregnancy terminations because of parental concern about the impact of the skin disease.1, 2 The present study suggests that dermatologists can expect to see patients with STS deletions identified unexpectedly through newer technologies. These cases incidentally found by CMA to have an STS deletion lacked the polygonal or “dirty” scales considered the hallmark of XLI; more common findings
References (37)
- et al.
Characterization of point mutations in patients with X-linked ichthyosis: effects on the structure and function of the steroid sulfatase protein
J Biol Chem
(1997) - et al.
X-linked ichthyosis: an oculocutaneous genodermatosis
J Am Acad Dermatol
(2010) - et al.
Undetectable maternal serum unconjugated estriol levels in the second trimester: risk of perinatal complications associated with placental sulfatase deficiency
Am J Obstet Gynecol
(1997) - et al.
Steroid sulphatase deficiency associated with testis cancer
Lancet
(1983) - et al.
Xp22.3 interstitial deletion: a recognizable chromosomal abnormality encompassing VCX3A and STS genes in a patient with X-linked ichthyosis and mental retardation
Gene
(2013) - et al.
Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies
Am J Hum Genet
(2010) - et al.
Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities
Genet Med
(2010) - et al.
Steroid sulfatase deficiency with bilateral periventricular nodular heterotopia
Pediatr Neurol
(2006) - et al.
Deletion of distal promoter of VCXA in a patient with X-linked ichthyosis associated with borderline mental retardation
J Dermatol Sci
(2007) - et al.
Role of cholesterol sulfate in epidermal structure and function: lessons from X-linked ichthyosis
Biochim Biophys Acta
(2014)
Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Soreze 2009
J Am Acad Dermatol
Prevalence of steroid sulfatase deficiency in California according to race and ethnicity
Prenat Diagn
Steroid sulfatase deficiency and contiguous gene deletion syndrome amongst pregnant patients with low serum unconjugated estriols
Prenat Diagn
Analysis of the STS gene in 40 patients with recessive X-linked ichthyosis: a high frequency of partial deletions in a Spanish population
J Eur Acad Dermatol Venereol
X-linked ichthyosis due to steroid-sulphatase deficiency
Lancet
Clinical spectrum of steroid sulfatase deficiency: X-linked recessive ichthyosis, birth complications and cryptorchidism
Eur J Pediatr
Steroid sulfatase inhibitors
Med Res Rev
Testis cancer: ichthyosis constitutes a significant risk factor
Cancer
Cited by (0)
Funding sources: None.
Conflicts of interest: None declared.